Back Home Search

Neuroblastoma

  • newly diagnosed1
  • relapsed/refractory2
  • Protocols

  • ANBL2131

    OPEN TO ACCRUAL

    Ph3 HR Neuroblastoma with Dinutuximab and Multimodal Therapy